The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Transfer

13 Oct 2015 17:45

RNS Number : 1627C
Tungsten Corporation PLC
13 October 2015
 



TUNGSTEN CORPORATION PLC 

 

("Tungsten" or the "Company")

 

For Immediate Release

 

13 October 2015

 

Director Share Transfer

 

The Company has been informed that on 13th October 2015, Edmund Truell, Vice Chairman of the Company, agreed to transfer 817,802 ordinary shares in the Company to Danny Truell, a Non-Executive Director of the Company, in exchange for a total of 29.5505 A shares in Disruptive Capital Investments Limited, a private entity controlled by the Truell family.

 

550,000 of these ordinary shares have been transferred today with the remaining 267,802 ordinary shares expected to be settled on or before 30th November 2015.

 

Following this transaction, Edmund Truell and Danny Truell will have beneficial interests in 19,887,283* and 1,247,802 ordinary shares of the Company, respectively, representing 15.86% and 0.99% of the total voting rights of the Company.

 

* This is the total number of Edmund Truell's direct and indirect holdings. The indirect holdings are held via Disruptive Capital Investments Limited, his family vehicle.

 

Enquiries:

 

Tungsten Corporation plc.

Richard Hurwitz, Chief Executive Officer

Juliana Wheeler, Head of Global Communications (Media)

 

+44 20 7280 7713

+44 20 7280 7973

Charles Stanley Securities

(Nominated Adviser and Joint Broker)

Dugald J. Carlean

 

 

+44 20 7149 6000

Canaccord Genuity Limited

(Joint Broker)

Simon Bridges/Emma Gabriel

 

 

+44 20 7523 8000

Neustria Partners (Investors and Analysts)

Robert Bailhache/Nick Henderson/Charles Gorman

 

+44 20 3021 2580

 

About Tungsten Corporation plcTungsten Corporation (LSE: TUNG) accelerates global trade by enabling customers to streamline invoice processing, improve cash-flow management and make better buying decisions from their detailed spend data.

 

Buyer organisations that join Tungsten Network, the world's largest compliant electronic invoicing network, can reduce their invoice-processing costs by 60%. Suppliers benefit from efficiencies, greater visibility of their invoice status and peace of mind. Tungsten offers options for supply chain financing and helps buying organisations profit by applying real-time spend analytics to its vast repository of line-level invoice data.

 

Tungsten serves 56% of the Fortune 500 and 67% of the FTSE 100 by connecting the world's largest companies and government agencies to their thousands of suppliers around the globe. It enables suppliers to submit tax compliant e-Invoices in 47 countries, and last year processed transactions worth over $187bn for organisations such as Alliance Data, Aviva, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg's, and the US Federal Government.

 

Contact: Juliana Wheeler, Head of Global Communications, +44 20 7280 7973.

juliana.wheeler@tungsten-network.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMJBFTMBIBBJA
Date   Source Headline
15th Dec 20212:41 pmRNSStatement Re Possible Offer for Tungsten Corp
15th Dec 20212:35 pmEQSForm 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
15th Dec 20212:12 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Tungsten Corporation plc
15th Dec 20212:00 pmRNSForm 8.3 - Tungsten
15th Dec 20211:45 pmRNSForm 8.3
15th Dec 202112:13 pmBUSForm 8.3 - Tungsten Corporation plc
14th Dec 20215:35 pmRNSStatement re Possible Offer
14th Dec 20213:18 pmRNSStatement re Possible Offer
13th Dec 20217:01 amRNSInterim Results
13th Dec 20217:00 amRNSUS Litigation Settlement
7th Dec 20217:00 amRNSInvestor Presentation
3rd Dec 20217:00 amRNSPartnership Agreement
1st Dec 202111:27 amRNSHolding(s) in Company
30th Nov 202111:15 amRNSHolding(s) in Company
29th Nov 20214:41 pmRNSSecond Price Monitoring Extn
29th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSHolding(s) in Company
25th Nov 20217:00 amRNSHolding(s) in Company
23rd Nov 20213:02 pmRNSHolding(s) in Company
22nd Nov 20215:44 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSCustomer Win
2nd Nov 20217:10 amRNSCustomer Contract Cancellation
15th Oct 20213:28 pmRNSResult of AGM
14th Oct 20214:36 pmRNSHolding(s) in Company
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:07 amRNSISAE 3402 Accreditation
23rd Sep 20217:00 amRNSPosting of Report and Accounts and Notice of AGM
16th Sep 20215:03 pmRNSDirector Appointment
16th Sep 20218:40 amRNSSupply Chain Finance Partnership
27th Aug 20217:00 amRNSAdditional Listing and Total Voting Rights
23rd Aug 20217:00 amRNSDirector/PDMR Shareholdings
30th Jul 20217:00 amRNSFinal Results
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSDirectorate Change
10th Jun 20214:40 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSChange of Chief Executive Officer
7th Jun 20217:00 amRNSCustomer Win
4th Jun 20217:00 amRNSTrading Update
20th May 20217:00 amRNSAppointment of Chief Financial Officer
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20217:00 amRNSCustomer Win
30th Mar 202112:15 pmRNSAdditional Listing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.